ARLINGTON, Va.--(BUSINESS WIRE)--Jul 22, 2025--
Healthcare technology pioneer DrFirst announced today that Laizer Kornwasser, a transformative healthcare executive with a track record of driving rapid growth, has been named chief executive officer, effective July 21, 2025. G. Cameron Deemer, who has served as CEO since 2023 and president for 15 years, will continue to support the company’s strategic initiatives as vice chairman of the board of directors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250722311228/en/
This planned succession reinforces DrFirst’s commitment to innovation and growth, building on 25 years of healthcare technology leadership. Today, the company develops end-to-end medication management solutions that reach over 100 million patients annually through integrations and partnerships with electronic systems used by hospitals, medical practices, and pharmacies nationwide.
Kornwasser brings over two decades of healthcare leadership experience across pharmacy, telemedicine, chronic care, pharmaceutical companies, and PBMs. Most recently, he served as president of enterprise growth and emerging markets at Teladoc Health. He previously held senior executive roles at CareCentrix and Medco Health. Kornwasser holds an MBA from Harvard Business School and has served as a professor at Yeshiva University’s Sy Syms School of Business.
“What drew me to this company is its consistent ability to identify gaps in medication management and create effective solutions to close those gaps, while maintaining an unwavering commitment to customers and employees,” said Kornwasser. “DrFirst has built something extraordinary—patented AI technologies, the nation’s largest medication management network, and deep integration with virtually every major EHR system. I’m excited to lead this exceptional team as we accelerate our strategy and continue to deliver comprehensive, interoperable solutions.”
Market-leading portfolio
Under founder James Chen’s and Deemer’s leadership, DrFirst established first-to-market innovations now used industry-wide, including:
“As we prepared for DrFirst’s next growth phase, we were seeking a leader who could embrace our vision and scale our market-leading platform,” said Deemer. “Laizer’s proven ability to drive aggressive growth while building cultures that attract and retain top talent makes him ideal to lead DrFirst going forward.”
Chen, who founded DrFirst in 2000 and led the company through its emergence as a healthcare technology leader, now serves as executive chairman of the board. He added, “Laizer’s extraordinary track record of business transformation and operational excellence across multiple healthcare sectors aligns perfectly with our vision for the company’s future. His leadership will be instrumental as we pursue rapid growth.”
Industry recognition validates market position
The company was recently honored to receive Frost & Sullivan’s 2025 Enabling Technology Leadership Recognition, which noted, “With a record of continuous innovation and strategic expansion, DrFirst is well-positioned as a key player in the healthcare industry, fostering collaboration and optimizing care at every stage of the patient journey.”
In recent years, the company has won over 25 awards for excellence, including Gold in the prestigious Edison Awards for its clinical-grade AI that streamlines healthcare workflows and prevents medication errors.
About DrFirst
For 25 years, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. We improve healthcare workflows and help patients start and stay on therapy with end-to-end solutions that enhance prescription access, affordability, and adherence. Our solutions help 100 million patients a year and are used by more than 450,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. To learn more, visit DrFirst.com.
DrFirst Names Laizer Kornwasser as CEO
